|
|
|
|
|
by incrudible
1604 days ago
|
|
Consistent waning of efficacy against infection over time has been observed regardless of variants[1]. At the same time, we didn't see "massive benefit" against severe cases in breakthrough infections in a matched cohort study[2]. This leads me to suspect that current statistical observations do not reflect reality and may well be artifacts. Paradoxically, we're also observing increased odds of Omikron infection after (two dose) vaccination. Furthermore, we're administering boosters even to teenagers based on good faith, not good science. Hence, there still is a need for placebo-controlled trials. [1] https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3949410 [2] https://www.medrxiv.org/content/10.1101/2021.10.26.21265508v... |
|
https://www.wsj.com/articles/covid-19-vaccine-booster-shot-c...